Predictive Factors of Failure or Success of Sedation With Dexmedetomidine in ICU
Phase of Trial: Phase IV
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Sedation
- Focus Therapeutic Use
- 25 Nov 2014 Planned primary completion date changed from 1 Jul 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.
- 25 Nov 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 30 Jul 2014 New trial record